The Port Delivery System with ranibizumab: a new paradigm for long-acting retinal drug delivery
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Port Delivery System with ranibizumab: a new paradigm for long-acting retinal drug delivery
Authors
Keywords
-
Journal
DRUG DELIVERY
Volume 29, Issue 1, Pages 1326-1334
Publisher
Informa UK Limited
Online
2022-05-02
DOI
10.1080/10717544.2022.2069301
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In-vitro characterization of ranibizumab release from the Port Delivery System
- (2022) Stefan Yohe et al. JOURNAL OF CONTROLLED RELEASE
- Ocular Drug Delivery to the Retina: Current Innovations and Future Perspectives
- (2021) Hyeong Min Kim et al. Pharmaceutics
- Port delivery system: a novel drug delivery platform to treat retinal diseases
- (2021) Arshad M. Khanani et al. Expert Opinion on Drug Delivery
- Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration
- (2021) Nancy M. Holekamp et al. OPHTHALMOLOGY
- Use of biomaterials for sustained delivery of anti-VEGF to treat retinal diseases
- (2020) Ivan Seah et al. EYE
- Long-Term Stability of Anti-Vascular Endothelial Growth Factor (a-VEGF) Biologics Under Physiologically Relevant Conditions and Its Impact on the Development of Long-Acting Delivery Systems
- (2020) Debby P. Chang et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Nonclinical Toxicology and Biocompatibility Program Supporting Clinical Development and Registration of the Port Delivery System With Ranibizumab for Neovascular Age-Related Macular Degeneration
- (2020) Vladimir Bantseev et al. TOXICOLOGIC PATHOLOGY
- The Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration
- (2019) Peter A. Campochiaro et al. OPHTHALMOLOGY
- Diabetic Retinopathy Preferred Practice Pattern®
- (2019) Christina J. Flaxel et al. OPHTHALMOLOGY
- Age-Related Macular Degeneration Preferred Practice Pattern®
- (2019) Christina J. Flaxel et al. OPHTHALMOLOGY
- EVALUATION OF SURGICAL FACTORS AFFECTING VITREOUS HEMORRHAGE FOLLOWING PORT DELIVERY SYSTEM WITH RANIBIZUMAB IMPLANT INSERTION IN A MINIPIG MODEL
- (2019) Vladimir Bantseev et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Optimizing Anti-VEGF Treatment Outcomes for Patients with Neovascular Age-Related Macular Degeneration
- (2018) Charles C. Wykoff et al. Journal of Managed Care & Specialty Pharmacy
- Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis
- (2017) Seth R Flaxman et al. Lancet Global Health
- Biochemical analysis of the living human vitreous
- (2016) Jan Kokavec et al. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Five-Year Outcomes with Anti–Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration
- (2016) Maureen G. Maguire et al. OPHTHALMOLOGY
- Disease Burden in the Treatment of Age-Related Macular Degeneration: Findings From a Time-and-Motion Study
- (2015) Jonathan L. Prenner et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Implantable MicroPump for Drug Delivery in Patients with Diabetic Macular Edema
- (2014) Mark Humayun et al. Translational Vision Science & Technology
- DETERMINATION OF RETINAL AND VITREOUS TEMPERATURE IN VITRECTOMY
- (2011) Maurice B Landers et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Diabetic retinopathy
- (2010) Ning Cheung et al. LANCET
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation